Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;30(6):1474-1494.
doi: 10.1007/s00586-021-06718-2. Epub 2021 Jan 24.

Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review

Affiliations

Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review

Seyed Mohammad Piri et al. Eur Spine J. 2021 Jun.

Abstract

Purpose: Macrophages play an important role in mediating damage after Spinal cord injury (SCI) by secreting macrophage migration inhibitory factor (MMIF) as a secondary injury mediator. We aimed to systematically review the role of MMIF as a therapeutic target after traumatic SCI.

Methods: Our systematic review has been performed according to the PRISMA 2009 Checklist. A systematic search in the scientific databases was carried out for studies published before 20 February 2019 from major databases. Two researchers independently screened titles. The risk of bias of eligible articles was assessed, and data were extracted. Finally, we systematically analyzed and interpreted related data.

Results: 785 papers were selected for the title and abstract screening. 12 papers were included for data extraction. Eight animal studies were of high quality and the remaining two were of medium quality. One of the two human studies was of poor quality and the other was of fair quality. MMIF as a pro-inflammatory mediator can cause increased susceptibility to glutamate-related neurotoxicity, increased nitrite production, increased ERK activation, and increased COX2/PGE2 signaling pathway activation and subsequent stimulation of CCL5-related chemotaxis. Two human studies and six animal studies demonstrated that MMIF level increases after SCI. MMIF inhibition might be a potential therapeutic target in SCI by multiple different mechanisms (6/12 studies).

Conclusion: Most animal studies demonstrate significant neurologic improvement after administration of MMIF inhibitors, but these inhibitors have not been studied in humans yet. Further clinical trials are need to further understand MMIF inhibitor utility in acute or chronic SCI.

Level of evidence i: Diagnostic: individual cross-sectional studies with the consistently applied reference standard and blinding.

Keywords: Macrophage migration inhibitory factors; Spinal cord injury; Systematic review; macrophage.

PubMed Disclaimer

References

    1. Stein A, Panjwani A, Sison C, Rosen L, Chugh R, Metz C, Bank M, Bloom O (2013) Pilot Study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury. Arch Phys Med Rehabil 94:1498–1507. https://doi.org/10.1016/j.apmr.2013.04.004 - DOI - PubMed
    1. Saxena T, Loomis KH, Pai SB, Karumbaiah L, Gaupp E, Patil K, Patkar R, Bellamkonda RV (2015) Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury. ACS Nano 9:1492–1505. https://doi.org/10.1021/nn505980z - DOI - PubMed
    1. Hagg T, Oudega M (2006) Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23:264–280 - PubMed
    1. Hall ED (2011) Antioxidant therapies for acute spinal cord injury. Neurotherapeutics 8:152–167 - DOI
    1. Tator CH, Fehlings MG (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15–26 - DOI

Publication types

Substances

LinkOut - more resources